Chikungunya Outbreak Progresses in Caribbean, Central and South America
US testing for chikungunya is unlikely to taper off during the fall and winter, as travelers returning from outbreak areas remain at risk.
Read More
Search Results for: infectious diseases
Chembio Earns CLIA Waiver for HIV 1/2 Assay, Opening Door to Expansion
Chembio Diagnostics has received a CLIA waiver from FDA for its DPP HIV 1/2 assay, enabling the company to expand into new channels such as physician office labs, clinics, and other community healthcare facilities.
Read More
From the Editor: Call and Response
Public health authorities in the United States are working hard to prevent the spread of ebola—and much of that work centers on the need for advanced clinical diagnostics.
Read More
BioFire Defense Gets Fast-Track Authorization for FilmArray Ebola Test
Under an FDA emergency use authorization, BioFire’s commercial BioThreat-E test for the ebola Zaire virus is now available to high- and moderate-complexity clinical laboratories in the United States.
Read More
TB Test Kit Simultaneously Detects Antibiotic Resistance
A microscopic observation of drug susceptibility test kit from Hardy Diagnostics detects Mycobacterium tuberculosis while simultaneously detecting the strain’s resistance to isoniazid and rifampicin, the two most common tuberculosis antibiotics.
Read More